Rodentalis - Company finances
|
EUR
|
2022
From: 2022-03-18
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 76,744 | 171,084 | 171,047 | 156,602 |
| Profit before tax | 14,193 | 41,433 | 36,867 | -16,366 |
| Net profit | 14,193 | 39,361 | 35,006 | -16,366 |
| Equity | 14,194 | 53,556 | 35,008 | -16,363 |
| Liabilities | 3,744 | 5,374 | 28,879 | 36,328 |
| Non-current assets | 6,099 | 5,456 | 3,920 | 2,816 |
| Current assets | 11,839 | 53,474 | 59,967 | 17,149 |
| Total assets | 17,938 | 58,930 | 63,887 | 19,965 |
|
Taxes paid
|
||||
| STI taxes | - | 7,420 | 8,887 | 10,834 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +122.9% | 0.0% | -8.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 79.1% | 66.8% | 54.8% | -82.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 73.5% | 100.0% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 18.5% | 23.0% | 20.5% | -10.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 18.5% | 24.2% | 21.6% | -10.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.1 | 0.8 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 171,047 | 156,602 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Rodentalis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-26 | 2026-08-09 | 0.52 |
| 2026-07-23 | 2026-07-25 | 0.87 |
| 2026-07-19 | 2026-07-22 | 0.52 |
| 2026-07-16 | 2026-07-17 | 275.62 |
| 2026-06-16 | 2026-07-15 | 0.52 |
| 2026-05-18 | 2026-06-04 | 0.52 |
| 2026-05-17 | 2026-05-17 | 340.84 |
| 2026-05-03 | 2026-05-14 | 0.52 |
| 2026-04-24 | 2026-04-29 | 0.52 |
| 2026-03-27 | 2026-03-27 | 250.76 |
| 2026-03-17 | 2026-03-23 | 250.76 |
| 2023-02-01 | 2023-02-28 | 7.68 |
| 2022-05-03 | 2022-05-31 | 50.95 |
Rodentalis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-08-10 | 0.14 |
| 2025-06-19 | 2026-02-03 | 0.07 |
| 2025-04-30 | 2025-06-12 | 0.07 |
| 2025-04-17 | 2025-04-29 | 0.38 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Rodentalis, MB (code 306045635) is a small partnership engaged in diagnostic imaging services and medical laboratory activities. In 2025, the latest financial year, the company generated revenue of €156.6K, down 8.4% year on year and 8.5% compared with 2023. After two profitable years, performance deteriorated in 2025 and the business reported a net loss of €16.4K, compared with net profit of €35.0K in 2024 and €39.4K in 2023. The profit margin moved from 23.0% in 2023 and 20.5% in 2024 to -10.5% in 2025. Total assets at year-end 2025 were €20.0K, with short-term assets of €17.1K and long-term assets of €2.8K. Liabilities increased to €36.3K, leaving equity at -€16.4K. Asset turnover remained high at 7.84x, while revenue per employee was €156.6K and profit per employee was -€16.4K. The latest figures show a company with declining sales, weaker profitability and a compressed balance sheet.